Zobrazeno 1 - 6
of 6
pro vyhledávání: '"José Luis Gonzálvez Perales"'
Autor:
Vicente Ruiz‐García, Eduardo López‐Briz, Rafael Carbonell‐Sanchis, Sylvia Bort‐Martí, José Luis Gonzálvez‐Perales
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 9, Iss 3, Pp 444-452 (2018)
Abstract In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome. The mechanism by which MA increases
Externí odkaz:
https://doaj.org/article/a09fc9a140c448f7ab75e039bc08375f
Autor:
Eduardo López-Briz, Sylvia Bort-Marti, Vicente Ruiz-García, José Luis Gonzálvez-Perales, Rafael Carbonell-Sanchis
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle. 9:444-452
In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome. The mechanism by which MA increases appetite
Autor:
Vicente, Ruiz-García, Eduardo, López-Briz, Rafael, Carbonell-Sanchis, Sylvia, Bort-Martí, José Luis, Gonzálvez-Perales
Publikováno v:
Journal of cachexia, sarcopenia and muscle. 9(3)
In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome. The mechanism by which MA increases appetite
Publikováno v:
Atencion Primaria
Publikováno v:
Medicina Clínica. 119:356
Publikováno v:
Medicina Clínica. 119:359